SUPPLEMENTAL INFORMATION As a foreign private issuer under the rules and regulations of the U.S. Securities and Exchange Commission, Fresenius Medical Care AG & Co, KGaA (hereinafter also referred to as FMC AG & Co. KGaA

SUPPLEMENTAL INFORMATION

As a foreign private

issuer under the rules and regulations of the U.S. Securities and Exchange

Commission, Fresenius Medical Care AG & Co, KGaA (hereinafter also referred

to as FMC AG & Co. KGaA, the Company , we or our ) is not presently

subject to the SEC s Proxy Rules. However, under the stipulations of the

Pooling Agreement among us, Fresenius SE, our general partner and our

independent directors, FMC AG & Co. KGaA has agreed to provide information to

shareholders which is roughly comparable to that which would be provided by a

U.S. corporation, except that it agreed to provide the following information as

it would be provided by a foreign private issuer under the SEC s rules:

(i) Security Ownership of

Certain Beneficial Owners of Fresenius Medical Care AG & Co. KGaA; (ii)

Trading markets: (iii) Directors and Senior Management; (iv) Compensation of

our Management Board and our Supervisory Board; (v) Options to Purchase Our

Securities, and (vi) material transactions between FMC AG & Co. KGaA and

its subsidiaries and directors and officers of FMC AG & Co. KGaA,

controlling persons of FMC AG & Co. KGaA, and relatives or spouses of such

directors, officers and controlling persons. The above information contained in

this letter has been extracted from our Annual Report on Form 20-F for the year

ended December 31, 2007 filed with the SEC (our 2007 20-F ). Our 2007 20-F is

available on the web site maintained by the SEC at www.sec.gov and on our web

site at www.fmc-ag.com.

Security Ownership of Certain

Beneficial Owners of Fresenius Medical Care AG & Co. KGaA

Our outstanding share

capital consists of ordinary shares and non-voting preference shares that are

issued only in bearer form. Accordingly, unless we receive information

regarding acquisitions of our shares through a filing with the Securities and

Exchange Commission or through the German statutory requirements referred to

below, we have no way of determining who our shareholders are or how many

shares any particular shareholder owns except as described below with respect

to our shares held in American Depository Receipt ( ADR ) form. Because we are

a foreign private issuer under the rules of the Securities and Exchange

Commission, our directors and officers are not required to report their

ownership of our equity securities or their transactions in our equity

securities pursuant to Section 16 of the Exchange Act. Under the German

Securities Exchange Law (Wertpapierhandelsgesetz), however,

persons who discharge managerial responsibilities within an issuer of shares

are obligated to notify the issuer and the German Federal Financial Supervisory

Authority of their own transactions in shares of the issuer. This obligation

also applies to persons who are closely associated with the persons discharging

managerial responsibility. Additionally, holders of voting securities of a

German company listed on the Regulated Market (Regulated Market) of a

German stock exchange or a corresponding trading segment of a stock exchange

within the European Union are obligated to notify the company of the level of

their holding whenever such holding reaches, exceeds or falls below certain

thresholds, which are 3%,

5%, 10%, 15%, 20%, 25%, 30%, 50% and 75%. The notification obligations also

apply to option agreements (excluding the 3% threshold).

Fresenius SE is the only entity that beneficially owns more than 5% of our

outstanding ordinary shares. We have been informed that as of December 31,

2006, Fresenius SE owned 36.4% of our ordinary shares.

Security Ownership of Certain

Beneficial Owners of Fresenius SE

SE s share capital consists of ordinary shares and non-voting preference

shares. Both classes of shares are issued only in bearer form. Accordingly,

Fresenius SE has no way of determining who its shareholders are or how many

shares any particular shareholder owns. However, under the German Securities

Exchange Law, holders of voting securities of a German company listed on the

Regulated Market (Regulated Market) of a German stock exchange or a

corresponding trading segment of a stock exchange within the European Union are

obligated to notify the company of certain levels of holdings, as described

on the most recent information available, Else Kr ner-Fresenius Foundation owns

approximately 60% of the Fresenius SE Ordinary shares. According to Allianz

Lebensversicherungs AG, they hold between 5%-10% of the Fresenius SE Ordinary

The principal trading

market for our ordinary shares and our preference shares is the Frankfurt Stock

Exchange. The ordinary shares of Fresenius Medical Care AG ( FMC-AG ) had been

listed on the Frankfurt Stock Exchange since October 2, 1996, the preference shares

since November 25, 1996. Trading in the ordinary shares and preference shares

of FMC-AG & Co. KGaA on the Frankfurt Stock Exchange commenced on February

Our shares are listed on

the Regulated Market (Regulierter Markt) of the Frankfurt Stock

Exchange and on the sub-segment Prime Standard of the Regulated Market. The

Prime Standard is a sub-segment of the Regulated Market with additional

post-admission obligations. Admission to the Prime Standard requires the

fulfillment of the following transparency criteria: publication of quarterly

reports; preparation of financial statements in accordance with international financial reporting

standards (IFRS or US-GAAP); publication of a company calendar;

convening of at least one analyst conference per year; publication of ad-hoc

messages (i.e., certain announcements of material developments and events) in

English. Companies aiming to be listed in this segment have to apply for

admission. Listing in the Prime Standard is a prerequisite for inclusion of

shares in the selection indices of the Frankfurt Stock Exchange, such as the

DAX, the index of 30 major German stocks.

Since October 1, 1996,

ADSs each representing one-third of an Ordinary share, and commencing June 15,

2007 following a 3-for-1 share split, each representing one Ordinary share (the

Ordinary ADSs ), have been listed and traded on the New York Stock Exchange

( NYSE ) under the symbol FMS. Since November 25, 1996, ADSs, each representing

one-third of a Preference share and, commencing June 15, 2007 following a

3-for-1 share split, each representing one Preference share (the Preference

ADSs ), have been listed and traded on the NYSE under the symbol FMC/P. At

December 31, 2007, there were 96,233 preference ADSs outstanding. Accordingly,

while the preference ADSs remain listed on the New York Stock Exchange, the

trading market for the preference ADSs is highly illiquid. In addition, the New

York Stock Exchange has advised us that if the number of publicly held

preference ADSs falls below 100,000, that preference ADSs could be delisted.

The Depositary for both the Ordinary ADSs and the Preference ADSs is The Bank